Sarah J. Shepherd
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
50
Citations
2,513
Est. group size
—
Recurring co-author estimate
Active years
21
Publishing since 2006
Sarah J. Shepherd's research focuses on lipid nanoparticles (LNPs), which are tiny fat-based particles used to deliver genetic material like mRNA or siRNA into cells for therapeutic purposes, such as vaccines and gene therapies. Her work spans the design, manufacturing, and biophysical characterization of these nanoparticles, including microfluidic (small-scale fluid-handling chip) production methods and studies of how nanoparticle structure relates to their function in delivering drugs to specific tissues like the lungs, liver, and bone marrow.
Publication output has grown substantially over the past decade, rising from about 1-2 papers per year before 2021 to a peak of 9 in 2023, with continued strong activity through 2024-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Author Correction: Elucidating lipid nanoparticle properties and structure through biophysical analyses
Nature Biotechnology · 2026
- Elucidating lipid nanoparticle properties and structure through biophysical analyses
Nature Biotechnology · 2025
- Automated and Parallelized Microfluidic Generation of Large and Precisely Defined Lipid Nanoparticle Libraries
ACS Nano · 2025
- Automated and parallelized microfluidic generation of large and precisely-defined lipid nanoparticle libraries
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Insights into mRNA lipid nanoparticle polydispersity and shape using quantitative solution biophysics
Structural Dynamics · 2025
- Improv in health professions education special interest group: Creating community and collaboration
Patient Education and Counseling · 2025
- High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models
Nature Communications · 2024
- Combinatorial design of siloxane-incorporated lipid nanoparticles augments intracellular processing for tissue-specific mRNA therapeutic delivery
Nature Nanotechnology · 2024
- Nanoparticle-based DNA vaccine protects against SARS-CoV-2 variants in female preclinical models
Nature Communications · 2024
- Robust, Scalable Microfluidic Manufacturing of RNA–Lipid Nanoparticles Using Immobilized Antifouling Lubricant Coating
ACS Nano · 2024
- Microfluidic Generation of Diverse Lipid Nanoparticle Libraries
Nanomedicine · 2024
- Towards the clinical translation of a silver sulfide nanoparticle contrast agent: large scale production with a highly parallelized microfluidic chip
European Journal of Nuclear Medicine and Molecular Imaging · 2024
- Elucidating lipid nanoparticle properties and structure through biophysical analyses
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Nanoparticle protein corona: from structure and function to therapeutic targeting
Lab on a Chip · 2023
- Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
Nature Communications · 2023
- Nature Communications×4
- bioRxiv (Cold Spring Harbor Laboratory)×4
- Patient Education and Counseling×3
- Proceedings of the National Academy of Sciences×2
- Journal of Biomedical Materials Research Part A×2
- Shi Du
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Krishan Kumar
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Yonger Xue
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Robert J. Lee
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Congcong Xu
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile